Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Exercise or conversion 10b5-1 +32,395 $8.93 $289K 145,165
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −25,390 $62.02 $1.6M 119,775
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −17,284 $62.62 $1.1M 102,491
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −1,600 $63.69 $102K 100,891
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Sale 10b5-1 −400 $65.31 $26K 100,491
2026-09-15 Inrig Jula EVP, Head of R&D & CMO Exercise or conversion · Employee stock option (right to buy) 10b5-1 −32,395 43,605
2026-06-22 Inrig Jula CHIEF MEDICAL OFFICER Gift −468 112,770
2026-05-06 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −311 $43.95 $14K 113,238
2026-05-05 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −2,174 $46.65 $101K 113,549
2026-05-04 Inrig Jula CHIEF MEDICAL OFFICER Exercise or conversion 10b5-1 +20,000 $22.40 $448K 131,473
2026-05-04 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −20,000 $45.00 $900K 111,473
2026-05-04 Inrig Jula CHIEF MEDICAL OFFICER Exercise or conversion 10b5-1 +4,250 115,723
2026-05-04 Inrig Jula CHIEF MEDICAL OFFICER Exercise or conversion · Employee stock option (right to buy) 10b5-1 −20,000 34,500
2026-05-04 Inrig Jula CHIEF MEDICAL OFFICER Grant or award · Performance-based restricted stock units 10b5-1 +8,500 8,500
2026-05-04 Inrig Jula CHIEF MEDICAL OFFICER Exercise or conversion · Performance-based restricted stock units 10b5-1 −4,250 4,250
2026-04-15 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −1,018 $42.61 $43K 111,473
2026-04-14 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −7,215 $41.93 $303K 112,491
2026-04-13 Inrig Jula CHIEF MEDICAL OFFICER Grant or award 10b5-1 +14,000 119,706
2026-02-04 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −1,547 $32.11 $50K 105,938
2026-02-04 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −232 $32.85 $8K 105,706

Page 1 of 3 · 54 trades